Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Applied Toxicology : JAT|September 11, 2012
Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcomeBaichun Yang, Thomas PapoianJournal of Applied Toxicology : JAT|January 26, 2018
Preclinical approaches to assess potential kinase inhibitor-induced cardiac toxicity: Past, present and futureBaichun Yang, Thomas PapoianJournal of Applied Toxicology : JAT|February 28, 2018
Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicityXi Yang, Thomas PapoianDrug Discovery Today|February 5, 2017
Safety of antisense oligonucleotide and siRNA-based therapeuticsXuan Chi, Philip Gatti, Thomas PapoianBasic & Clinical Pharmacology & Toxicology|May 17, 2006
Application of genomics in preclinical drug safety evaluationPeter G Lord, Alex Nie, Michael McMillianToxicology Mechanisms and Methods|December 22, 2009
The evolution of gene expression studies in drug safety assessmentPeter G Lord, Alex Nie, Michael McMillianEnvironmental Health Perspectives|March 23, 2004
Toxicogenomics in risk assessment: an overview of an HESI collaborative research programWilliam Pennie, Syril D Pettit, Peter G LordToxicologic Pathology|April 20, 2017
Regulatory Forum Review*: Utility of in Vitro Secondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory ConsiderationsThomas Papoian, Gowraganahalli Jagadeesh, Muriel Saulnier, et al.Biochemical Pharmacology|December 12, 2003
Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growthSarah E Crunkhorn, Kathryn E Plant, Gordon G Gibson, et al.Pageof 2